Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
Date | Form | Description | XBRL | Pages | |
---|---|---|---|---|---|
09/28/09 | Statement of changes in beneficial ownership of securities | 2 | |||
09/28/09 | Initial statement of beneficial ownership of securities | 4 | |||
09/28/09 | Statement of changes in beneficial ownership of securities | 1 | |||
09/28/09 | Initial statement of beneficial ownership of securities | 1 | |||
08/21/09 | Statement of changes in beneficial ownership of securities | 1 | |||
07/23/09 | Statement of changes in beneficial ownership of securities | 1 | |||
07/23/09 | Statement of changes in beneficial ownership of securities | 1 | |||
07/23/09 | Statement of changes in beneficial ownership of securities | 1 | |||
07/23/09 | Statement of changes in beneficial ownership of securities | 2 | |||
07/23/09 | Statement of changes in beneficial ownership of securities | 2 |